• Dbv Technologies SA DBVT.OQ reported a quarterly adjusted loss of $1.55​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.70. The lone analyst forecast for the quarter was for a loss of 13 cents per share.

• Revenue rose 26.2% to $1.47 million from a year ago; analysts expected $712.50 thousand.

• Dbv Technologies SA shares had risen by 6.2% this quarter and gained 214.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 33.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."

• Wall Street's median 12-month price target for Dbv Technologies SA is $20.00, about 51% above its last closing price of $9.80

This summary was machine generated from LSEG data July 29 at 09:53 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)